SPOTLIGHT: Thailand reconsiders compulsory licenses

Thailand's new public health minister has pledged to review his country's compulsory licensing of four cancer medicines--two made by Novartis, one by Sanofi-Aventis, and another by Roche. Under the previous minister, Thailand was aggressively using compulsory licenses to circumvent patent protection on drugs so it could obtain lower-cost versions. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.